Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1

Conditions

Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Thyroid Neoplasms 1Rectal Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Neuroendocrine Tumors 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Myocarditis 1Multiple Pulmonary Nodules 1Liver Metastases 1Hematologic Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Neuroendocrine 1Carcinoma, Lobular 1Breast Neoplasms 1

Interventions

pembrolizumab 39Bevacizumab 25Cyclophosphamide 23Blood Specimen Collection 19Standard of Care 17Nivolumab 17Carboplatin 17Paclitaxel 15Exercise 15Gemcitabine 14atezolizumab 13Pemetrexed 13Cisplatin 13Radiotherapy 11Fluorouracil 11Doxorubicin 11Cetuximab 10130-nm albumin-bound paclitaxel 10durvalumab 9Rituximab 9Oxaliplatin 9Magnetic Resonance Spectroscopy 9Leucovorin 9Docetaxel 9Biopsy 9abemaciclib 8Temozolomide 8Surveys and Questionnaires 8Prednisone 8olaparib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms × Positron Emission Tomography Computed Tomography × 90 days × Clear all
NCT05513027 2026-05-08

Augmented Whole-body Scanning Via Magnifying PET/CT (AWSM-PET/CT) Techniques Abilities to Improve Upon the Diagnostic Accuracy of the Standard-of-care (SOC) PET/CT for Malignant Lesion Detection

Washington University School of Medicine

Phase NA Terminated
11 enrolled
Tumor-Agnostic

Neoplasms

NCT07487883 2026-04-02

Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors

Peking University People's Hospital

Recruiting
80 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms, Multiple Pulmonary Nodules

Data powered by HemOnc (CC BY 4.0) Colophon âš¡